Cadre Holdings Inc
For the period ended Dec 31, 2024. Filed Mar 11, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 11, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
We require all executive officers and directors to effect purchase and sale transactions in the Company’s securities pursuant to a trading plan (each, a “10b5-1 Plan”) intended to satisfy the requirements of Rule 10b5-1 under the Exchange Act (“Rule 10b5-1”). We limit executive officers to a single 10b5-1 Plan in effect at any time, subject to limited exceptions in accordance with Rule 10b5-1. The following table includes the material terms (other than with respect to the price) of each 10b5-1 Plan adopted or terminated by our executive officers and directors during the quarter ended December 31, 2024:
| · · · · · · | |||
|---|---|---|---|
| · · Date of · · Scheduled · · Aggregate number of | |||
| · · adoption · · expiration date · · shares of common stock | |||
| Name and Title | of 10b5-1 Plan(1) | of 10b5-1 Plan(2) | to be purchased or sold(3) |
| Warren B. KandersChief Executive Officer and Chairman of the Board of Directors | December 22, 2024 | September 30, 2025 | 1,000,000 |
| (1) | Transactions under each Rule 10b5-1 Plan commence no earlier than 90 days after adoption, or such later date as required by Rule 10b5-1. |
| (2) | Each Rule 10b5-1 Plan may expire on such earlier date as all transactions are completed. |
| (3) | Each Rule 10b5-1 Plan provides for shares to be sold on multiple predetermined dates. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.